MSKCC patient education on medical cannabis for cancer-related symptoms.
Cannabis
Cannabis is a supplement, botanical, or biologic intervention discussed for symptom support, inflammation, immune modulation, metabolism, detoxification, or direct anticancer claims depending on the source. In cancer care, it should be evaluated by evidence level, intended use, safety, interactions, and whether it is being used as conventional treatment, supportive care, an experimental adjunct, or an alternative claim.
NCI professional summary on cannabis/cannabinoids for cancer-related symptoms, pharmacology, studies, and safety.
Randomized trial reporting 1:1 THC:CBD oil was no better than palliative care alone for symptoms in advanced cancer.
PubMed record for ASCO cannabis/cannabinoids guideline.
ASCO guideline recommending evidence-based education, discussing limited evidence, and advising against cancer-directed use outside clinical trials.
Narrative review of randomized trials of cannabinoids for cancer-related symptoms.
Review of cannabis/cannabinoids in cancer pain management.
Major consensus report on cannabis health effects.
Classic review of cannabinoid anticancer mechanisms and preclinical evidence.
MSKCC herb monograph on cannabis, mechanisms, evidence, cautions, and oncology guidance.
NCI patient summary on cannabis/cannabinoids for symptoms and FDA approval status.
FDA source on cannabis, approved cannabinoid drugs, research, and regulation.